Loading…
IBA signed a contract with Proton International Arkansas LLC to install a ProteusONE proton therapy solution at the UAMS Winthrop P. Rockefeller Cancer Institute in Little Rock, Arkansas. The system is expected to start treating patients by 2023, with a typical end-user price range of USD 40-50 million including a 10-year maintenance contract.
“The contract includes a long-term operation and maintenance agreement to be provided by IBA, with Proton International LLC expecting to start treating patients by 2023.”globenewswire.com
Summarized from public sources; check the original articles before acting on it.